5Iishigame H,Nakajima A,Saijo S,et al. The role of TNFalpha and IL- 17 in the development of excess IL-I signaling-induced inflammatory diseases in IL-I receptor antagonist-deficient mice [ J ]. EmstSchering Res Found Workshop. 2006, (56) :129 - 153.
6Sarah G, Hymowitz, Ellen H, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding[ J ]. The EMBO Journal 2001 ,20 ( 19 ) :5332 - 5341.
7Akimzhanov AM, Yang XO, Dong C. Chromatin remodeling of interleu- kin-17 (IL-17) -IL-17F cytokine gene locus during inflammatory helper T cell differentiation[J]. J Biol Chem 2007,282(9) :5969 -5972.
8Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs[ J ]. Immunity 2008,29( 1 ) :44 -56.
9Ghoreschi K, Weigert C, Rocken M. lmmunopathogenesis and role of T ceils in psoriasis[J]. Clin Dermatol 2007,25(6) :574 -580.
10Dong C. Thl7 cells in development: an updated view of their molecular identity and genetic programming [J]. Nat Rev Immunol, 2008, 8(5)： 337-348.
